Biotech & Pharma: companies
Daily +2.03%Weekly −2.21%Monthly −1.31%266 companies · ₩232T
Korean Biotech & Pharma stocks: sector overview
The Biotech & Pharma sector has 266 companies listed on KOSPI and KOSDAQ, worth ₩232T in total. On Oct 30, 2026 the group moved up 2.03% (weighted by market value); the largest members are Samsung Biologics, Celltrion, Alteogen.
Key facts
- Stocks
- 266
- Total market value
- ₩232T
- Day's move
- +2.03%
- As of
- Oct 30, 2026
- Largest members
- Samsung Biologics, Celltrion, Alteogen
Earnings tracker · 4Q 2025
Past quarter
Combined, for the companies that have reported, vs the same quarter a year ago
| Company | Reported | Revenue | vs a year ago | Operating profit | vs a year ago | vs last quarter | Op. margin |
|---|---|---|---|---|---|---|---|
| Samsung Biologics | Mar 12 | ₩309B | −75.4% | ₩378B | +16.1% | −48.1% | 122.5%25.9% |
| Celltrion | Mar 16 | ₩1.3T | +25.1% | ₩475B | +141.9% | +57.6% | 35.7%18.5% |
| Alteogen | Mar 23 | ₩65B | +26.9% | ₩20B | −14.7% | −26.4% | 30.4%45.3% |
| SK biopharmaceuticals | Mar 18 | ₩194B | +19.2% | ₩46B | +13.8% | −34.0% | 23.8%24.9% |
| Yuhan | Mar 12 | ₩546B | +10.1% | ₩26B | Turned to profit | +18.5% | 4.8%−2.4% |
| HLB | Mar 23 | ₩29B | +13.6% | −₩29B | Bigger loss | Bigger loss | −102.5%−101.9% |
| Hanmi Pharm | Mar 20 | ₩433B | +23.1% | ₩83B | +173.4% | +51.2% | 19.2%8.7% |
| SAM Chun Dang Pharm | Mar 20 | ₩66B | +20.1% | ₩5.4B | Turned to profit | +58.0% | 8.2%−1.0% |
| SK Bioscience | Mar 13 | ₩184B | +17.4% | −₩52B | Bigger loss | Bigger loss | −28.0%−32.4% |
| LigaChem Biosciences | Mar 23 | ₩16B | −52.6% | −₩73B | Bigger loss | Bigger loss | −458.4%−40.7% |
| Hugel | Mar 20 | ₩119B | +21.3% | ₩58B | +24.5% | +22.0% | 48.5%47.3% |
| PharmaResearch | Mar 19 | ₩143B | +39.1% | ₩52B | +54.1% | −16.1% | 36.2%32.7% |
| ABL Bio | Mar 12 | ₩0 | −100.0% | −₩30B | Bigger loss | Bigger loss | — |
| Peptron | Mar 18 | ₩987M | −36.1% | −₩5.7B | Bigger loss | Smaller loss | −576.4%−227.4% |
| OliX Pharmaceuticals | Mar 18 | ₩4.5B | +9,920.3% | −₩8.5B | Bigger loss | Bigger loss | −186.7%−16,826.5% |
| Voronoi | Mar 20 | ₩22M | Turned to profit | −₩16B | Bigger loss | Bigger loss | −73,336.0% |
| Hanall Biopharma | Mar 18 | ₩38B | +3.1% | −₩2B | Turned to loss | Turned to loss | −5.4%7.5% |
| D&D Pharmatech | Mar 20 | ₩990M | −80.4% | −₩10B | Bigger loss | Bigger loss | −1,051.6%−135.7% |
| Caregen | Mar 16 | ₩16B | −23.6% | −₩7.1B | Turned to loss | Turned to loss | −43.4%28.7% |
| Celltrion Pharm | Mar 16 | ₩154B | +13.9% | ₩14B | +31.1% | −14.8% | 8.9%7.7% |
| Mezzion Pharma | Mar 20 | ₩2.1B | +8.3% | −₩5.1B | Bigger loss | Bigger loss | −242.3%−206.6% |
| Seegene | Mar 19 | ₩131B | +13.3% | ₩6.9B | Turned to profit | −27.7% | 5.3%−5.4% |
| GC Biopharma | Mar 18 | ₩498B | +12.9% | ₩4.6B | Turned to profit | −84.3% | 0.9%−2.3% |
| ST Pharm | Mar 18 | ₩129B | +11.5% | ₩26B | +15.3% | +78.4% | 20.3%19.7% |
| Naturecell | Mar 23 | ₩6.4B | −17.9% | −₩261M | Turned to loss | Smaller loss | −4.1%2.5% |
| OSCOTECInc | Mar 19 | ₩79B | +3,279.3% | ₩61B | Turned to profit | Turned to profit | 77.8%−301.2% |
| Aimed Bio | Mar 19 | ₩38B | — | ₩26B | — | — | 67.2% |
| Kolon TissueGene | Mar 18 | ₩585,091 | +7.3% | −₩5.6M | Bigger loss | Bigger loss | −950.1%−853.3% |
| Daewoong Pharma | Mar 18 | ₩397B | +7.9% | ₩43B | +12.0% | −23.8% | 10.9%10.5% |
| DongKook Pharmaceutical | Mar 12 | ₩243B | +15.1% | ₩24B | +37.6% | −2.0% | 10.0%8.4% |
| HK inno.N | Mar 18 | ₩292B | +23.8% | ₩40B | +64.5% | +55.0% | 13.7%10.3% |
| Daewoong | Mar 18 | ₩516B | +2.5% | ₩35B | −44.8% | −56.8% | 6.7%12.5% |
| Chong Kun Dang Pharmaceutical | Mar 18 | ₩427B | +2.7% | ₩23B | +247.1% | +11.9% | 5.5%1.6% |
| Boryung | — | ₩245B | −4.5% | −₩649M | Turned to loss | Turned to loss | −0.3%5.7% |
| JS Link | Mar 23 | ₩8.9B | +55.7% | −₩1.4B | Smaller loss | Smaller loss | −16.3%−30.0% |
| Komipharm International | — | ₩12B | −24.4% | −₩241M | Turned to loss | Turned to loss | −2.0%2.4% |
| L&C Bio | Mar 24 | ₩25B | +29.2% | ₩2B | Turned to profit | −32.5% | 7.9%−3.3% |
| Chabiotech | Mar 20 | ₩347B | +25.6% | −₩7.4B | Smaller loss | Smaller loss | −2.1%−14.3% |
| Qurient | Mar 18 | ₩1.5B | −45.8% | −₩9.3B | Bigger loss | Bigger loss | −606.2%−276.1% |
| Proteina | Mar 20 | ₩343M | — | −₩4.4B | — | Bigger loss | −1,295.4% |
| Rznomics | Mar 23 | ₩830M | Turned to profit | −₩5.4B | Bigger loss | Smaller loss | −655.8% |
| G2GBIO | Mar 18 | ₩203M | Turned to profit | −₩3B | Smaller loss | Smaller loss | −1,485.0% |
| Myungin Pharm | Mar 18 | ₩72B | — | ₩24B | — | — | 32.8% |
| JW Pharmaceutical | Mar 18 | ₩199B | +5.9% | ₩15B | −14.4% | −51.7% | 7.8%9.6% |
| Onconic Therapeutics | Mar 13 | ₩16B | — | ₩1.6B | — | −80.6% | 10.3% |
| BioNote | Mar 18 | ₩28B | +13.0% | ₩840M | −67.0% | −82.6% | 3.0%10.3% |
| Medy-Tox | Mar 19 | ₩61B | +10.0% | −₩3.7B | Turned to loss | Turned to loss | −6.1%1.7% |
| Shinpoong Pharmaceutical | Mar 20 | ₩58B | +5.0% | ₩3.9B | Turned to profit | −46.4% | 6.7%−21.9% |
| GI Innovation | Mar 18 | ₩5.5B | Turned to profit | −₩7.2B | Smaller loss | Smaller loss | −130.7% |
| HLB Pharmaceutical | Mar 19 | ₩63B | +91.7% | ₩835M | Turned to profit | +2,346.8% | 1.3%−3.7% |
| HLB Life Science | Mar 23 | ₩11B | −61.8% | −₩5.8B | Smaller loss | Bigger loss | −53.0%−23.9% |
| IL Dong Pharmaceutical | Mar 18 | ₩147B | −5.6% | ₩7.9B | −5.7% | +17.2% | 5.4%5.4% |
| Penetrium Bioscience | — | ₩1.9B | −20.9% | −₩1.6B | Smaller loss | Bigger loss | −80.4%−75.0% |
| T&L | Mar 18 | ₩33B | −28.2% | ₩4B | −64.0% | −66.9% | 12.0%24.0% |
| AbClon | Mar 13 | ₩1.6B | +128.6% | −₩5B | Bigger loss | Bigger loss | −308.4%−457.3% |
| Bukwang Pharmaceutical IND | Mar 16 | ₩63B | +35.4% | ₩8.2B | +317.8% | +733.2% | 13.0%4.2% |
| Curocell | Mar 19 | ₩0 | Flat | −₩8.7B | Smaller loss | Smaller loss | — |
| Orum Therapeutics | Mar 19 | ₩558,176 | — | −₩18B | — | Bigger loss | −3,270,387.0% |
| Dong-A ST | Mar 18 | ₩217B | +21.4% | −₩2.7B | Smaller loss | Turned to loss | −1.3%−4.1% |
| AprilBio | Mar 13 | ₩0 | −100.0% | −₩2B | Turned to loss | Smaller loss | — |
| Medipostco | Mar 19 | ₩18B | +0.4% | −₩21B | Bigger loss | Bigger loss | −118.7%−105.1% |
| Kwangdong Pharmaceutical | Mar 18 | ₩412B | +5.4% | ₩12B | +85.3% | +13.4% | 3.0%1.7% |
| Inventage Lab | Mar 23 | ₩1.1B | −0.6% | −₩7.5B | Bigger loss | Bigger loss | −701.4%−498.5% |
| Rokit Healthcare | Mar 23 | ₩9.6B | +161.5% | ₩600M | Turned to profit | +674.2% | 6.3%−54.1% |
| ToolGen | Mar 19 | ₩404M | +138.3% | −₩6.9B | Bigger loss | Bigger loss | −1,716.9%−3,346.5% |
| EuBiologics | Mar 17 | ₩32B | −12.2% | ₩14B | −18.1% | −28.0% | 42.1%45.1% |
| SillaJen | Mar 19 | ₩2.9B | +90.7% | −₩8.2B | Bigger loss | Bigger loss | −280.2%−490.0% |
| Korea United Pharm | Mar 16 | ₩73B | −0.7% | ₩13B | +6.0% | +0.2% | 17.3%16.2% |
| It-Chem | Mar 20 | −₩1.9B | — | ₩169M | — | Turned to profit | — |
| NKGen Biotech Korea | Mar 24 | ₩2.2B | −0.8% | −₩1.3B | Turned to loss | Turned to loss | −61.0%204.6% |
| Huons Global | Mar 23 | ₩225B | +10.9% | ₩19B | −26.2% | −4.7% | 8.6%13.0% |
| Samjin Pharmaceutical | Mar 16 | ₩81B | −4.7% | ₩4.2B | −54.0% | −56.8% | 5.2%10.9% |
| Humedix | Mar 20 | ₩46B | +22.8% | ₩11B | +9.3% | +24.0% | 24.2%27.2% |
| Genomictree | Mar 18 | ₩826M | +0.1% | −₩2.6B | Smaller loss | Smaller loss | −317.5%−443.3% |
| Hans Biomed | Feb 13 | ₩24B | +21.6% | −₩27B | Bigger loss | Turned to loss | −113.6%−5.4% |
| Prestige BioPharma | Mar 3 | ₩3.9M | Turned to profit | −₩10M | Bigger loss | Bigger loss | −258.8% |
| S.Biomedics | Mar 24 | ₩4B | −9.4% | −₩2.7B | Bigger loss | Bigger loss | −66.4%−24.9% |
| ImmuneOncia Therapeutics | Mar 18 | ₩0 | — | −₩9.6B | — | Smaller loss | — |
| Ilsung IS | Mar 18 | ₩15B | −13.1% | −₩2B | Smaller loss | Bigger loss | −13.7%−23.6% |
| IntoCell | Mar 18 | ₩728M | +547.5% | −₩1.9B | Smaller loss | Bigger loss | −256.8%−1,895.2% |
| Jetema | Mar 20 | ₩20B | +7.1% | ₩1.2B | Turned to profit | +15.2% | 5.8%−0.1% |
| FutureChem | Mar 18 | ₩6.2B | −1.2% | −₩1.4B | Smaller loss | Smaller loss | −22.9%−37.9% |
| KolmarBNH | Mar 17 | ₩122B | −14.0% | ₩2.6B | −17.9% | −72.7% | 2.2%2.3% |
| Hyundai Pharmaceutical | — | ₩49B | +13.7% | ₩43M | Turned to profit | −98.8% | 0.1%−4.7% |
| Huons | Mar 23 | ₩165B | +12.7% | ₩9.8B | −10.8% | −0.5% | 5.9%7.5% |
| BioPlus | Mar 20 | ₩23B | −20.3% | ₩963M | −93.0% | −80.3% | 4.2%47.5% |
| Binex | Mar 13 | ₩39B | +7.9% | −₩6.3B | Smaller loss | Turned to loss | −16.3%−19.8% |
| Daewon Pharmaceutical | Mar 18 | ₩160B | +10.2% | ₩5.9B | +82.0% | Turned to profit | 3.7%2.2% |
| Whanin Pharm | Mar 12 | ₩65B | −1.7% | ₩1.5B | +62.4% | −58.3% | 2.3%1.4% |
| Union Korea Pharm | Mar 31 | ₩6.5B | +64.8% | −₩2.6B | Smaller loss | Smaller loss | −40.9%−197.5% |
| HEM Pharma | Mar 18 | ₩3.7B | −41.9% | −₩6.8B | Bigger loss | Bigger loss | −184.1%−31.4% |
| Genome&Company | Mar 20 | ₩5.9B | −18.9% | −₩7B | Bigger loss | Smaller loss | −119.8%−73.5% |
| Vivozon Pharmaceutical | — | ₩16B | −30.3% | −₩3.7B | Turned to loss | Smaller loss | −23.0%2.2% |
| GC WellBeing | Mar 16 | ₩49B | +38.8% | ₩2.9B | +26.9% | −44.9% | 5.9%6.4% |
| Boditech Med | Mar 18 | ₩42B | +33.1% | ₩5.1B | +134.1% | −23.5% | 12.2%6.9% |
| Chongkundang Holdings | Mar 18 | ₩236B | +3.9% | ₩12B | +69.8% | −35.1% | 5.0%3.0% |
| curacle | Mar 18 | ₩0 | −100.0% | −₩4.7B | Bigger loss | Bigger loss | — |
| Kangstem Biotech | Mar 20 | ₩1.1B | −67.6% | −₩4.3B | Bigger loss | Bigger loss | −389.4%−59.1% |
| Bioneercorporation | Mar 24 | ₩80B | +13.4% | ₩2.7B | Turned to profit | −6.4% | 3.4%−10.5% |
| Reyon Pharmaceutical | Mar 20 | ₩34B | −9.2% | −₩8.2B | Bigger loss | Bigger loss | −24.1%−8.1% |
| DuChemBio | Mar 18 | ₩11B | — | ₩3B | — | +57.1% | 27.9% |
| DAE HWA Pharm | Mar 23 | ₩34B | −16.0% | ₩699M | −79.6% | −33.3% | 2.1%8.6% |
| Helixmith | Mar 20 | ₩490M | −70.0% | −₩2.4B | Bigger loss | Smaller loss | −484.2%−76.8% |
| Yungjin Pharm | Mar 12 | ₩67B | +6.3% | −₩1.1B | Turned to loss | Turned to loss | −1.6%2.5% |
| 3billion | Mar 23 | ₩3.9B | — | −₩1.1B | — | Smaller loss | −27.3% |
| Eone Diagnomics Genome Center | Mar 24 | ₩1.7B | −70.3% | −₩359M | Smaller loss | Smaller loss | −21.2%−73.3% |
| JW Lifescience | Mar 18 | ₩64B | +17.4% | ₩7.6B | −21.0% | +7.1% | 11.8%17.5% |
| Samil Pharmaceutical | Mar 18 | ₩53B | −8.3% | −₩8.6B | Bigger loss | Bigger loss | −16.2%−4.9% |
| Kolon Life Science | Mar 18 | ₩45B | −4.6% | −₩2.7B | Smaller loss | Turned to loss | −6.0%−6.9% |
| BNC Korea | Mar 23 | ₩24B | −8.6% | −₩2.4B | Turned to loss | Bigger loss | −10.0%6.7% |
| Nibec | Mar 20 | ₩6.1B | −3.8% | −₩1.2B | Smaller loss | Bigger loss | −18.8%−90.8% |
| Cellbion | Mar 20 | ₩382M | −32.6% | −₩2.5B | Bigger loss | Bigger loss | −657.6%−385.7% |
| Kyungdong Pharm | Mar 20 | ₩52B | +5.3% | ₩2.6B | +15.4% | −16.8% | 4.9%4.5% |
| Daehan Pharmaceutical | Mar 18 | ₩51B | −0.8% | ₩3.6B | −59.1% | −66.4% | 7.0%17.0% |
| Hana Pharm | Mar 20 | ₩60B | +4.9% | ₩5.8B | −34.9% | −30.0% | 9.7%15.6% |
| Aptabio Therapeutics | Mar 23 | ₩1B | +34.6% | −₩5.7B | Smaller loss | Bigger loss | −569.3%−887.7% |
| Dongwha Pharm | Mar 18 | ₩124B | +2.5% | −₩4B | Turned to loss | Turned to loss | −3.2%2.4% |
| ISU Abxis | Mar 12 | ₩11B | −47.1% | −₩7.8B | Turned to loss | Turned to loss | −71.8%25.4% |
| Bio Solution | Mar 19 | ₩4.4B | +23.2% | −₩485M | Bigger loss | Smaller loss | −11.0%−13.3% |
| Cell Biotech | Mar 18 | ₩15B | +20.4% | ₩3.1B | +171.0% | +37.8% | 20.9%9.3% |
| Y-Biologics | Mar 23 | ₩449M | −60.9% | −₩3B | Bigger loss | Bigger loss | −665.5%−205.9% |
| Ilyang Pharmaceutical | Mar 18 | ₩79B | +825.7% | ₩566M | Turned to profit | Turned to profit | 0.7%−0.5% |
| Jeil Pharmaceutical | Mar 16 | ₩132B | −29.3% | ₩534M | −77.6% | −94.6% | 0.4%1.3% |
| JW Shinyak | Mar 18 | ₩21B | +31.2% | ₩1.4B | Turned to profit | −47.2% | 6.7%−17.8% |
| Ahn-Gook Pharmaceutical | Mar 18 | ₩77B | +8.4% | −₩5.9B | Turned to loss | Turned to loss | −7.7%1.8% |
| Kyongbo Pharmaceutical | Mar 18 | ₩71B | +20.1% | ₩516M | −82.7% | +8.6% | 0.7%5.0% |
| Dongsung Pharmaceutical | Mar 23 | ₩19B | −15.5% | −₩7.1B | Bigger loss | Turned to loss | −37.3%−14.0% |
| Samsung Pharmaceutical | Mar 18 | ₩12B | +12.9% | −₩5.4B | Bigger loss | Bigger loss | −45.8%−27.6% |
| Handok | — | ₩140B | +15.5% | ₩4.5B | Turned to profit | +2,393.6% | 3.2%−2.4% |
| Kukjeon | Mar 23 | ₩30B | −6.0% | ₩136M | Turned to profit | Turned to profit | 0.4%−5.2% |
| TiumBio | Mar 18 | ₩4.4B | +200.1% | −₩2.8B | Smaller loss | Smaller loss | −62.6%−351.5% |
| MedPacto | Mar 18 | ₩1.4B | Turned to profit | −₩2.9B | Smaller loss | Smaller loss | −204.4% |
| Celemics | Mar 23 | ₩1.7B | −18.0% | −₩456M | Bigger loss | Smaller loss | −27.5%−7.0% |
| Optus Pharmaceutical | Mar 17 | ₩23B | −1.8% | ₩1.7B | −45.4% | −48.5% | 7.4%13.2% |
| Keeps Biopharma | Mar 23 | ₩45B | +37.7% | ₩1B | Turned to profit | −30.0% | 2.2%−4.0% |
| Sewoonmedical | Mar 20 | ₩17B | +10.2% | ₩3.7B | +60.4% | −0.3% | 22.6%15.5% |
| Asta | Mar 19 | ₩767M | −59.0% | −₩484M | Smaller loss | Smaller loss | −63.0%−43.2% |
| Metabiomed | — | ₩26B | +13.8% | ₩2.9B | −39.3% | −42.2% | 11.2%21.0% |
| Genexine | Mar 11 | ₩537M | +75.6% | −₩13B | Bigger loss | Bigger loss | −2,379.5%−2,499.5% |
| DreamCIS | Mar 23 | ₩19B | +30.9% | −₩388M | Turned to loss | Turned to loss | −2.0%18.4% |
| Aribiolab | Mar 17 | ₩0 | Flat | −₩5.4B | Bigger loss | Bigger loss | — |
| ViGenCell | Mar 18 | ₩14M | −93.7% | −₩6.3B | Bigger loss | Bigger loss | −45,073.8%−1,632.9% |
| DongKoo Bio & Pharma | Mar 23 | ₩62B | +7.5% | ₩2.8B | Turned to profit | +27.7% | 4.5%−0.8% |
| HLB bioStep | Mar 18 | ₩19B | +16.0% | −₩2.2B | Smaller loss | Turned to loss | −11.8%−29.0% |
| High Tech Pharm | Mar 12 | ₩14B | −27.8% | ₩3.2B | +13.3% | −18.9% | 22.6%14.4% |
| Aminologics | Mar 23 | ₩6.5B | +62.3% | ₩1.5B | Turned to profit | +4.4% | 22.4%−9.7% |
| Prestige Biologics | Feb 13 | ₩5.7B | Turned to profit | −₩4.2B | Bigger loss | Smaller loss | −73.6% |
| Sam-A Pharm | Mar 20 | ₩21B | +5.8% | ₩2.7B | −31.7% | Turned to profit | 12.8%19.8% |
| T&R Biofab | Mar 18 | ₩7.5B | +511.9% | −₩2.3B | Smaller loss | Bigger loss | −30.5%−212.6% |
| Vaxcell-Bio Therapeutics | Mar 16 | ₩1.7B | −5.7% | −₩3.6B | Smaller loss | Bigger loss | −214.9%−241.1% |
| Corestemchemon | Mar 19 | ₩4.9B | +0.6% | −₩3.1B | Smaller loss | Smaller loss | −62.4%−158.3% |
| iNtRON Biotechnology | Mar 11 | ₩1.7B | +12.0% | −₩2B | Bigger loss | Smaller loss | −119.7%−88.1% |
| Korea Pharma | Mar 19 | ₩19B | −11.4% | −₩2.3B | Turned to loss | Turned to loss | −11.9%8.8% |
| Withus Pharmaceutical | Mar 18 | ₩27B | +19.0% | ₩1.4B | +144.9% | +0.9% | 5.1%2.5% |
| Cellumed | Mar 23 | ₩28B | −22.8% | −₩649M | Smaller loss | Turned to loss | −2.3%−9.4% |
| Enzychem Lifesciences | Mar 24 | ₩14B | −23.9% | −₩4.4B | Smaller loss | Bigger loss | −31.1%−25.3% |
| Choong ANG Vaccine Laboratory | Mar 16 | ₩13B | +14.0% | ₩1.1B | +97.0% | −26.1% | 8.9%5.2% |
| Bio-Fd&C | — | ₩5.1B | +7.7% | ₩1.3B | −20.0% | −24.8% | 25.0%33.6% |
| HLB Genex | Mar 20 | ₩12B | +24.0% | −₩655M | Smaller loss | Bigger loss | −5.2%−14.5% |
| SCL Science | Mar 23 | ₩8.3B | +419.2% | −₩848M | Smaller loss | Turned to loss | −10.2%−85.5% |
| GC Medical Science | Mar 16 | ₩25B | −9.7% | ₩390M | −59.9% | −58.7% | 1.6%3.5% |
| Polaris AI Pharma | Mar 13 | ₩14B | −12.2% | −₩392M | Smaller loss | Turned to loss | −2.7%−6.8% |
| Eye Gene | Mar 19 | ₩774M | −41.0% | −₩3.3B | Bigger loss | Bigger loss | −420.4%−180.8% |
| Daehan Nupharm | Mar 18 | ₩52B | +1.6% | ₩2.3B | −38.3% | +12.4% | 4.5%7.4% |
| Shinil Pharmaceutical | — | ₩21B | −1.9% | −₩424M | Turned to loss | Turned to loss | −2.0%18.8% |
| Theragen Etex | Mar 19 | ₩69B | +5.3% | ₩4.2B | +75.1% | +117.2% | 6.1%3.7% |
| Daebonglsco | Mar 23 | ₩25B | +7.3% | ₩598M | −61.2% | −22.1% | 2.4%6.7% |
| Choolip & Sciences | Mar 13 | ₩1.8B | +90.8% | −₩1.9B | Bigger loss | Smaller loss | −110.7%−210.8% |
| Pharos iBio | Mar 19 | — | — | −₩2.9B | Bigger loss | Smaller loss | — |
| Samik Pharm | Mar 20 | ₩15B | — | ₩49M | — | −95.4% | 0.3% |
| Kukje Pharma | Mar 18 | ₩43B | +4.1% | −₩1.5B | Turned to loss | Turned to loss | −3.6%2.3% |
| Sugentech | Mar 18 | ₩2.9B | +16.4% | −₩5.1B | Smaller loss | Bigger loss | −178.1%−310.7% |
| Access Bio | Mar 23 | ₩3.6M | −83.4% | −₩15M | Turned to loss | Bigger loss | −435.9%15.3% |
| CKD Bio | Mar 18 | ₩42B | +34.4% | ₩109M | −48.0% | Turned to profit | 0.3%0.7% |
| DongKook Life Science | Mar 12 | ₩31B | — | ₩2.5B | — | −42.6% | 7.9% |
| Naturalendo Tech | Mar 16 | ₩5.2B | +7.3% | −₩831M | Smaller loss | Bigger loss | −16.0%−19.4% |
| Ildong Holdings | Mar 18 | ₩154B | −7.5% | ₩7.2B | +56.0% | +18.0% | 4.7%2.8% |
| CG Invites | Mar 19 | ₩12B | +338.9% | −₩3.8B | Smaller loss | Smaller loss | −31.6%−778.7% |
| SunBio | Mar 16 | ₩4.7B | +38.3% | ₩2.1B | +36.5% | +29.9% | 45.0%45.6% |
| PharmGen Science | Mar 23 | ₩43B | −3.2% | −₩753M | Turned to loss | Turned to loss | −1.8%4.2% |
| CTC Bio | Mar 18 | ₩32B | −22.1% | ₩1.5B | +85.4% | −3.4% | 4.8%2.0% |
| Optipharm | Mar 13 | ₩6B | +6.5% | −₩321M | Bigger loss | Smaller loss | −5.4%−4.5% |
| CMG Pharmaceutical | Mar 19 | ₩32B | +18.0% | ₩1B | +125.4% | −14.0% | 3.3%1.7% |
| Abion | Mar 19 | ₩66M | −69.5% | −₩5.6B | Smaller loss | Bigger loss | −8,472.1%−4,934.0% |
| Sinsin Pharmaceutical | Mar 18 | ₩29B | +13.8% | ₩3.3B | +189.9% | −15.7% | 11.6%4.6% |
| Adbiotech | Mar 23 | ₩3B | −36.0% | ₩346M | Turned to profit | Turned to profit | 11.6%−15.6% |
| Pangen Biotech | Mar 23 | ₩2.5B | −42.9% | −₩404M | Bigger loss | Turned to loss | −16.3%−6.4% |
| Humasis | Mar 23 | ₩6.4B | −46.1% | −₩3.3B | Bigger loss | Bigger loss | −51.8%−24.7% |
| Yuyu Pharma | Mar 18 | ₩34B | +4.2% | −₩129M | Smaller loss | Turned to loss | −0.4%−0.8% |
| HLB Panagene | Mar 17 | ₩4.2B | +21.9% | −₩1.7B | Bigger loss | Bigger loss | −39.6%−7.8% |
| Tego Science | — | ₩1.4B | −13.3% | −₩2.1B | Bigger loss | Bigger loss | −152.1%−68.3% |
| Cellid | Mar 23 | ₩2.8B | +49.2% | −₩3.7B | Bigger loss | Bigger loss | −131.1%−191.6% |
| NeoImmuneTech | Mar 19 | ₩27,007 | Turned to profit | −₩4.2M | Smaller loss | Bigger loss | −15,603.0% |
| Cytogen | Mar 20 | ₩6.5B | +17.2% | −₩2.6B | Bigger loss | Bigger loss | −39.1%−33.8% |
| KoBioLabs | Mar 19 | ₩15B | −14.4% | −₩3B | Bigger loss | Bigger loss | −19.6%−9.2% |
| ENCell | Mar 20 | ₩1.4B | −31.1% | −₩4.9B | Smaller loss | Bigger loss | −342.7%−263.4% |
| GeneOne Life Science | Mar 23 | ₩2.7B | −74.8% | −₩13B | Bigger loss | Bigger loss | −494.9%−93.9% |
| CJ Bioscience | Mar 16 | ₩1.3B | +33.7% | −₩5.2B | Smaller loss | Smaller loss | −410.0%−1,042.2% |
| JIN Yang Pharmaceutical | Mar 18 | ₩30B | +13.1% | −₩2.9B | Turned to loss | Bigger loss | −9.4%11.5% |
| Aprogen | Mar 23 | ₩32B | −20.5% | −₩27B | Smaller loss | Bigger loss | −85.4%−73.4% |
| Hwail Pharm | — | ₩19B | −30.3% | −₩1.3B | Bigger loss | Turned to loss | −7.0%−1.5% |
| Geninus | Mar 16 | ₩3.1B | +114.7% | −₩3B | Smaller loss | Bigger loss | −94.3%−245.8% |
| Gencurix | Mar 16 | ₩2.1B | −11.8% | −₩2.1B | Smaller loss | Bigger loss | −97.3%−91.8% |
| Quratis | Mar 23 | ₩260M | +216.1% | −₩2.2B | Smaller loss | Bigger loss | −834.1%−8,281.2% |
| RPbio | Mar 23 | ₩33B | +6.4% | ₩684M | +91.4% | +150.4% | 2.1%1.1% |
| Aprogen Biologics | Mar 20 | ₩20B | −7.6% | −₩16B | Smaller loss | Bigger loss | −78.5%−72.7% |
| Green Lifescience | Mar 19 | ₩13B | +81.7% | ₩1.2B | Turned to profit | +1,065.4% | 9.7%−6.2% |
| Wonbiogen | Mar 23 | ₩9.4B | +10.1% | ₩2.1B | +40.5% | −12.3% | 22.4%17.6% |
| Myungmoon Pharm | Mar 18 | ₩51B | +3.3% | ₩1.6B | −38.9% | +255.3% | 3.2%5.4% |
| Oncocross | Mar 19 | ₩141M | −78.5% | −₩2.2B | Smaller loss | Smaller loss | −1,567.1%−362.1% |
| HLB Pep | Mar 19 | ₩1.5B | +5.1% | −₩3.2B | Bigger loss | Bigger loss | −215.9%−91.3% |
| Kainos Medicine | — | ₩304M | +326.3% | −₩2.3B | Smaller loss | Bigger loss | −755.8%−5,858.3% |
| Organoidsciences | Mar 18 | ₩1.2B | — | −₩3.8B | — | Smaller loss | −313.3% |
| Eutilex | Mar 19 | ₩2.4B | −9.4% | −₩5B | Smaller loss | Bigger loss | −210.5%−288.9% |
| Orientbio | Feb 13 | ₩6.2B | +25.4% | ₩796M | −56.9% | Turned to profit | 12.9%37.5% |
| Kolmar BioTech | Mar 23 | ₩12B | +3.9% | −₩13M | Turned to loss | Smaller loss | −0.1%8.5% |
| IMBdx | Mar 20 | ₩1.7B | +168.6% | −₩2.2B | Smaller loss | Smaller loss | −128.0%−395.7% |
| Genolution | Mar 19 | ₩2.4B | +12.2% | −₩2B | Smaller loss | Smaller loss | −84.8%−97.7% |
| Kyung NAM Pharm | Mar 18 | ₩15B | −9.0% | ₩66M | −86.8% | Turned to profit | 0.5%3.1% |
| Hass | Mar 18 | ₩3.8B | −13.5% | ₩330M | −41.3% | +8.2% | 8.6%12.8% |
| Biotoxtech | — | ₩14B | +24.7% | −₩98M | Smaller loss | Smaller loss | −0.7%−12.3% |
| LabGenomics | Mar 23 | ₩21B | −5.3% | −₩26B | Bigger loss | Bigger loss | −122.0%−25.6% |
| Korean Drug | — | ₩18B | +1.7% | ₩1.9B | Turned to profit | −4.6% | 10.5%−14.0% |
| Bcworldpharm | Mar 13 | ₩20B | −5.8% | ₩719M | −63.4% | +387.4% | 3.5%9.1% |
| Genematrix | — | ₩2.9B | +9.2% | −₩191M | Smaller loss | Bigger loss | −6.7%−16.6% |
| Korea Arlico Pharm | Mar 19 | ₩48B | −7.7% | −₩1.7B | Bigger loss | Turned to loss | −3.5%−1.2% |
| Tdspharm | — | ₩8.7B | +54.5% | ₩1.6B | +442.6% | −1.6% | 18.6%5.3% |
| Dt&Cro | Mar 20 | ₩15B | +29.2% | ₩621M | Turned to profit | Turned to profit | 4.1%−4.7% |
| Poongjeon Pharmacy | Mar 16 | ₩2.1B | +1,210.1% | −₩1.1B | Smaller loss | Smaller loss | −52.6%−1,743.8% |
| Daesung Microbiological Labs | Mar 16 | ₩6.9B | +1.9% | −₩270M | Turned to loss | Turned to loss | −3.9%10.7% |
| Shaperon | Mar 19 | ₩48M | Turned to profit | −₩4.4B | Bigger loss | Bigger loss | −9,183.7% |
| Seoul Pharma | Mar 19 | ₩14B | −2.0% | −₩217M | Turned to loss | Bigger loss | −1.6%4.5% |
| MFC | Mar 23 | ₩5B | — | −₩454M | — | Turned to loss | −9.1% |
| WooGene B&Gco | Mar 19 | ₩13B | −0.1% | ₩459M | Turned to profit | Turned to profit | 3.4%−8.3% |
| Telcon RF Pharmaceutical | Mar 19 | ₩13B | −3.7% | ₩2.6B | −16.2% | Turned to profit | 19.7%22.6% |
| Xcell Therapeutics | Mar 19 | ₩1.1B | +123.2% | −₩3.3B | Bigger loss | Bigger loss | −306.2%−524.5% |
| PeopleBio | Mar 23 | ₩154M | −76.7% | −₩1.7B | Smaller loss | Smaller loss | −1,133.8%−282.3% |
| Celestra | Mar 24 | −₩1.3B | Turned to loss | −₩168M | Smaller loss | Smaller loss | — |
| Olipass | Mar 20 | ₩129M | Turned to profit | −₩1.7B | Smaller loss | Bigger loss | −1,290.4% |
| ChoA Pharmaceutical | Mar 13 | ₩16B | −7.0% | −₩1.5B | Smaller loss | Bigger loss | −9.5%−20.2% |
| MOA Life Plus | Mar 23 | ₩4.6B | +44.3% | −₩2.8B | Smaller loss | Bigger loss | −60.7%−114.1% |
| Curachem | Not yet | ||||||
| NovMetaPharma | Not yet | ||||||
| BioInfra | Not yet | ||||||
| Pharmaresearch Bio | Not yet | ||||||
| Ensol Biosciences | Not yet | ||||||
| Epi Biotech | Not yet | ||||||
| BASKHANBIOPharma | Not yet | ||||||
| Invites Biocore | Not yet | ||||||
| AngioLab | Not yet | ||||||
| Plumbline Life Sciences | Not yet | ||||||
| Moogene Medi | Not yet | ||||||
| Imgt | Not yet | ||||||
| ProGen | Not yet | ||||||
| Cronex | Not yet | ||||||
| Medizen Humancare | Not yet | ||||||
| BioInfra Life Science | Not yet | ||||||
| PCL | Not yet | ||||||
| QuadMedicine | Not yet | ||||||
| Ingenia Therapeutics | Not yet | ||||||
| Samyang Biopharm | Not yet | ||||||
| IMBiologics | Not yet | ||||||
| Kanaph Therapeutics | Not yet | ||||||
| Inventera | Not yet | ||||||
| HL Genomics | Not yet | ||||||
| Median Diagnostics | Not yet | ||||||
Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.
Technical breadth
After the close on Oct 30, 2026- Above 20-day average
- 7.3%
- Above 60-day average
- 14.7%
- RSI above 70
- 0.4%
- RSI below 30
- 16.8%
- 52-week highs
- 0
- 52-week lows
- 34
Index gauge · Short term
Bearish
0 bullish, 2 neutral, 7 bearish
Index gauge · Medium term
Bearish
0 bullish, 1 neutral, 7 bearish
Technical read
Across the 232 Biotech & Pharma members, only 7.3% trade above their 20-day averages and 14.7% above their 60-day averages, showing very weak short- and medium-term breadth. Of the members, 34 sit at 52-week lows while none sit at 52-week highs, and RSI readings are concentrated at the oversold end with 0.4% at the high extreme and 16.8% at the low. The equal-weighted member index is rated bearish on both short and medium horizons, with an RSI of 32.2 and price positioned below its cloud. Taken together, the technical picture for this group has been one of broad weakness over the recent period.
Written by AI from the indicator values above. Not advice.
Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Credit & macro
- MaturitiesOct 23, 202685ISU Abxis: ₩50bn of bonds due in the next 6 months vs ₩23bn cash₩50bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.ISU Abxis
- MaturitiesOct 23, 202685GC Biopharma: ₩130bn of bonds due in the next 6 months vs ₩42bn cash₩130bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.GC Biopharma
- MaturitiesOct 22, 202675Boryung: ₩86bn of bonds due in the next 6 months vs ₩50bn cash₩86bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.Boryung
- MaturitiesOct 20, 202685SK Reit: ₩130bn of bonds due in the next 6 months vs ₩54bn cash₩350bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2025 FY.SK ReitSK hynixSK NetworksSK DiscoverySKCSK Telecom
| Company | Price | Daily | Weekly | Monthly | Traded value | Market cap | NPS |
|---|---|---|---|---|---|---|---|
Samsung Biologics207940 · KOSPI | ₩1,487,000 | +8.86% | +1.43% | +7.36% | ₩144B | ₩69T | 6.88% |
Celltrion068270 · KOSPI | ₩191,600 | +1.22% | −1.44% | +7.10% | ₩100B | ₩44T | 7.28% |
Alteogen196170 · KOSDAQ | ₩211,500 | −3.86% | −5.79% | −16.57% | ₩71B | ₩15T | 2.68% |
SK biopharmaceuticals326030 · KOSPI | ₩77,700 | −0.13% | +1.04% | +3.74% | ₩12B | ₩6.1T | 6.00% |
Yuhan000100 · KOSPI | ₩75,100 | +0.54% | −11.33% | +2.88% | ₩20B | ₩5.5T | 6.83% |
HLB028300 · KOSDAQ | ₩40,000 | +0.76% | −3.85% | −0.37% | ₩30B | ₩5.3T | 1.16% |
Hanmi Pharm128940 · KOSPI | ₩415,000 | +6.82% | +14.80% | −18.15% | ₩103B | ₩5.3T | 9.61% |
SAM Chun Dang Pharm000250 · KOSDAQ | ₩182,700 | −3.13% | −8.28% | +9.99% | ₩15B | ₩4.3T | 1.34% |
SK Bioscience302440 · KOSPI | ₩32,750 | +1.71% | −1.21% | −8.77% | ₩2.9B | ₩2.6T | 5.50% |
LigaChem Biosciences141080 · KOSDAQ | ₩61,500 | −3.91% | −9.82% | −22.64% | ₩8.6B | ₩2.3T | 4.99% |
Hugel145020 · KOSDAQ | ₩179,800 | −1.91% | −0.17% | −1.91% | ₩6.4B | ₩2.3T | 2.29% |
PharmaResearch214450 · KOSDAQ | ₩212,000 | −4.72% | −11.48% | −33.02% | ₩17B | ₩2.2T | 7.14% |
ABL Bio298380 · KOSDAQ | ₩39,200 | −4.39% | −11.41% | −20.49% | ₩11B | ₩2.2T | 4.02% |
Peptron087010 · KOSDAQ | ₩92,300 | −5.04% | −11.67% | −30.02% | ₩14B | ₩2.2T | 1.63% |
OliX Pharmaceuticals226950 · KOSDAQ | ₩94,000 | −2.59% | −9.00% | −8.56% | ₩15B | ₩2.2T | 5.04% |
Voronoi310210 · KOSDAQ | ₩106,100 | −7.90% | −19.98% | −19.86% | ₩9.3B | ₩2T | 2.78% |
Hanall Biopharma009420 · KOSPI | ₩37,500 | −0.79% | −6.72% | −13.29% | ₩5B | ₩2T | 10.56% |
D&D Pharmatech347850 · KOSDAQ | ₩40,850 | −2.04% | +0.25% | −2.62% | ₩20B | ₩1.9T | 1.75% |
Caregen214370 · KOSDAQ | ₩33,150 | −2.36% | −7.66% | −20.50% | ₩2B | ₩1.8T | 0.65% |
Celltrion Pharm068760 · KOSDAQ | ₩36,650 | −0.41% | −2.53% | −5.05% | ₩1.4B | ₩1.6T | 0.49% |
Mezzion Pharma140410 · KOSDAQ | ₩51,200 | −2.66% | −11.11% | −30.62% | ₩4.8B | ₩1.6T | 0.50% |
Seegene096530 · KOSDAQ | ₩33,250 | −1.04% | −1.77% | −1.34% | ₩5.6B | ₩1.6T | 0.64% |
GC Biopharma006280 · KOSPI | ₩130,200 | −1.36% | −1.51% | +5.68% | ₩3.2B | ₩1.5T | 6.68% |
ST Pharm237690 · KOSDAQ | ₩72,500 | −2.03% | −19.35% | −22.29% | ₩8.5B | ₩1.5T | 5.77% |
Naturecell007390 · KOSDAQ | ₩21,800 | −1.80% | −5.83% | −10.47% | ₩2.7B | ₩1.4T | 0.44% |
OSCOTECInc039200 · KOSDAQ | ₩36,450 | −0.14% | −2.15% | +2.24% | ₩4.5B | ₩1.4T | 3.87% |
Aimed Bio0009K0 · KOSDAQ | ₩18,860 | −4.99% | −9.76% | −12.28% | ₩3.1B | ₩1.2T | 0.03% |
Kolon TissueGene950160 · KOSDAQ | ₩13,920 | −2.66% | −9.73% | −7.57% | ₩3.3B | ₩1.2T | 0.57% |
Daewoong Pharma069620 · KOSPI | ₩101,100 | −0.39% | −1.27% | −5.78% | ₩3.1B | ₩1.2T | 10.30% |
Ingenia Therapeutics950260 · KOSDAQ | ₩22,350 | −4.89% | +3.23% | −11.66% | ₩3.2B | ₩1.1T | — |
DongKook Pharmaceutical086450 · KOSDAQ | ₩23,450 | −1.88% | −4.09% | +9.58% | ₩7.6B | ₩1.1T | 3.33% |
HK inno.N195940 · KOSDAQ | ₩34,250 | −1.15% | +0.44% | −13.62% | ₩3B | ₩970B | 5.03% |
Daewoong003090 · KOSPI | ₩15,110 | +1.41% | +1.07% | −3.39% | ₩934M | ₩879B | 3.25% |
Chong Kun Dang Pharmaceutical185750 · KOSPI | ₩63,100 | +0.96% | −2.47% | −2.02% | ₩1.5B | ₩871B | 6.34% |
Boryung003850 · KOSPI | ₩8,310 | −0.24% | −0.84% | +0.48% | ₩384M | ₩713B | 4.12% |
JS Link127120 · KOSDAQ | ₩18,230 | −5.05% | +6.24% | −38.62% | ₩3.4B | ₩682B | 5.05% |
Komipharm International041960 · KOSDAQ | ₩9,070 | +3.66% | +5.22% | −6.49% | ₩2.2B | ₩677B | 0.02% |
L&C Bio290650 · KOSDAQ | ₩23,950 | −4.58% | −20.56% | +0.77% | ₩5.5B | ₩646B | 1.28% |
Chabiotech085660 · KOSDAQ | ₩6,750 | −0.15% | −5.73% | −17.48% | ₩1B | ₩628B | 0.31% |
Qurient115180 · KOSDAQ | ₩16,590 | −6.95% | −14.79% | −19.07% | ₩1.4B | ₩623B | 3.88% |
Proteina468530 · KOSDAQ | ₩54,300 | +0.74% | +24.97% | +1.31% | ₩13B | ₩603B | 3.78% |
Rznomics476830 · KOSDAQ | ₩21,300 | −5.96% | −9.36% | −10.69% | ₩6.4B | ₩600B | 3.96% |
G2GBIO456160 · KOSDAQ | ₩35,600 | −2.73% | −28.37% | +5.01% | ₩8B | ₩592B | 2.41% |
Myungin Pharm317450 · KOSPI | ₩40,100 | +1.01% | −1.72% | −4.86% | ₩557M | ₩585B | 0.68% |
JW Pharmaceutical001060 · KOSPI | ₩23,000 | −0.65% | −3.77% | −13.21% | ₩642M | ₩565B | 2.44% |
Onconic Therapeutics476060 · KOSDAQ | ₩12,110 | −4.04% | −6.41% | −21.00% | ₩2B | ₩550B | — |
BioNote377740 · KOSPI | ₩4,650 | +0.54% | +1.31% | +0.11% | ₩264M | ₩474B | 0.81% |
Medy-Tox086900 · KOSDAQ | ₩63,900 | −0.47% | −5.19% | −4.77% | ₩624M | ₩466B | 1.44% |
Shinpoong Pharmaceutical019170 · KOSPI | ₩8,350 | −0.71% | −3.69% | −7.02% | ₩2.1B | ₩438B | 0.39% |
GI Innovation358570 · KOSDAQ | ₩6,730 | −3.03% | −12.82% | −15.56% | ₩2.3B | ₩434B | 4.07% |
HLB Pharmaceutical047920 · KOSDAQ | ₩9,500 | −0.11% | −7.77% | −21.03% | ₩9.5B | ₩414B | — |
HLB Life Science067630 · KOSDAQ | ₩3,295 | +0.46% | −6.26% | −9.23% | ₩489M | ₩402B | 0.07% |
IL Dong Pharmaceutical249420 · KOSPI | ₩12,580 | +0.08% | −1.56% | −8.64% | ₩6.7B | ₩398B | 2.30% |
Penetrium Bioscience187660 · KOSDAQ | ₩6,100 | −1.13% | +5.72% | −18.56% | ₩3.1B | ₩390B | — |
T&L340570 · KOSDAQ | ₩23,750 | −2.06% | −2.66% | −13.95% | ₩689M | ₩382B | 0.99% |
AbClon174900 · KOSDAQ | ₩18,470 | −5.81% | −14.29% | −15.08% | ₩5.4B | ₩369B | 3.57% |
Bukwang Pharmaceutical IND003000 · KOSPI | ₩3,670 | −0.81% | −3.42% | −7.56% | ₩953M | ₩362B | 0.68% |
Curocell372320 · KOSDAQ | ₩23,050 | −2.74% | −0.43% | +6.47% | ₩514M | ₩351B | 0.46% |
Orum Therapeutics475830 · KOSDAQ | ₩15,320 | −3.10% | −5.78% | −31.91% | ₩2.5B | ₩333B | 0.09% |
Dong-A ST170900 · KOSPI | ₩33,850 | −0.44% | −2.17% | −2.45% | ₩502M | ₩329B | 4.78% |
AprilBio397030 · KOSDAQ | ₩11,810 | −4.76% | −7.37% | −36.81% | ₩3B | ₩325B | 0.95% |
Medipostco078160 · KOSDAQ | ₩8,090 | −3.11% | −4.49% | −10.61% | ₩485M | ₩317B | 1.55% |
Kwangdong Pharmaceutical009290 · KOSPI | ₩6,240 | −1.11% | −5.31% | −1.42% | ₩1B | ₩311B | 0.80% |
Inventage Lab389470 · KOSDAQ | ₩22,100 | −3.91% | −9.24% | −6.95% | ₩1.1B | ₩294B | 0.31% |
Rokit Healthcare376900 · KOSDAQ | ₩16,810 | −13.57% | −0.59% | −38.65% | ₩6.4B | ₩294B | 0.19% |
Samyang Biopharm0120G0 · KOSPI | ₩38,650 | −5.50% | −11.15% | −14.87% | ₩1.4B | ₩287B | 1.73% |
ToolGen199800 · KOSDAQ | ₩29,200 | −5.65% | +4.66% | −15.48% | ₩1.1B | ₩285B | 0.43% |
EuBiologics206650 · KOSDAQ | ₩7,730 | −0.90% | +5.46% | −6.08% | ₩598M | ₩281B | 0.17% |
SillaJen215600 · KOSDAQ | ₩2,020 | −1.94% | −6.48% | −12.17% | ₩871M | ₩280B | 0.09% |
Korea United Pharm033270 · KOSPI | ₩16,910 | +0.36% | −0.70% | −4.41% | ₩778M | ₩269B | 2.76% |
It-Chem309710 · KOSDAQ | ₩21,000 | 0.00% | 0.00% | 0.00% | ₩0 | ₩268B | — |
NKGen Biotech Korea182400 · KOSDAQ | ₩3,670 | 0.00% | 0.00% | 0.00% | ₩0 | ₩265B | — |
Huons Global084110 · KOSDAQ | ₩20,350 | −2.86% | −8.33% | −7.29% | ₩586M | ₩258B | 0.64% |
Samjin Pharmaceutical005500 · KOSPI | ₩19,250 | −0.62% | −1.79% | +2.78% | ₩613M | ₩256B | 2.05% |
Humedix200670 · KOSDAQ | ₩22,650 | −1.52% | −4.43% | −9.58% | ₩470M | ₩250B | 1.03% |
Genomictree228760 · KOSDAQ | ₩9,970 | +0.71% | +6.06% | −8.95% | ₩580M | ₩248B | 0.51% |
Hans Biomed042520 · KOSDAQ | ₩17,030 | −2.85% | −5.18% | −19.10% | ₩891M | ₩243B | 4.88% |
Prestige BioPharma950210 · KOSPI | ₩4,020 | −3.25% | −22.24% | −33.44% | ₩349M | ₩242B | 0.15% |
S.Biomedics304360 · KOSDAQ | ₩19,190 | −2.09% | −5.93% | −6.84% | ₩468M | ₩240B | — |
ImmuneOncia Therapeutics424870 · KOSDAQ | ₩2,515 | −3.27% | −14.02% | −25.37% | ₩925M | ₩230B | — |
Ilsung IS003120 · KOSPI | ₩21,150 | −2.98% | −1.63% | −2.53% | ₩121M | ₩225B | 0.44% |
IntoCell287840 · KOSDAQ | ₩14,890 | −4.12% | −10.68% | −10.52% | ₩275M | ₩224B | 1.04% |
Jetema216080 · KOSDAQ | ₩5,860 | −1.01% | −3.14% | −12.93% | ₩421M | ₩219B | 0.01% |
FutureChem220100 · KOSDAQ | ₩6,930 | −7.35% | −22.91% | +3.43% | ₩1.6B | ₩215B | 0.76% |
KolmarBNH200130 · KOSDAQ | ₩7,410 | −5.36% | −1.98% | −5.36% | ₩573M | ₩213B | 0.34% |
Hyundai Pharmaceutical004310 · KOSPI | ₩6,570 | −1.65% | −3.24% | −22.98% | ₩2.3B | ₩210B | 0.58% |
Huons243070 · KOSDAQ | ₩16,960 | −0.41% | −2.36% | −10.41% | ₩449M | ₩203B | 0.71% |
BioPlus099430 · KOSDAQ | ₩3,200 | −6.16% | −6.02% | −3.61% | ₩528M | ₩197B | 0.42% |
Binex053030 · KOSDAQ | ₩6,030 | −0.82% | −2.43% | −2.90% | ₩446M | ₩197B | 2.17% |
IMBiologics493280 · KOSDAQ | ₩13,160 | −4.64% | −9.43% | −23.80% | ₩1.6B | ₩195B | — |
Daewon Pharmaceutical003220 · KOSPI | ₩8,680 | +12.73% | +9.32% | +11.86% | ₩13B | ₩195B | 0.90% |
Whanin Pharm016580 · KOSPI | ₩10,400 | −0.76% | +1.96% | +3.17% | ₩359M | ₩193B | 3.12% |
Union Korea Pharm080720 · KOSDAQ | ₩2,410 | 0.00% | 0.00% | 0.00% | ₩0 | ₩192B | — |
HEM Pharma376270 · KOSDAQ | ₩26,200 | +0.19% | −5.92% | −19.01% | ₩118M | ₩189B | — |
Genome&Company314130 · KOSDAQ | ₩3,505 | −3.71% | −10.24% | −21.94% | ₩773M | ₩188B | 0.24% |
Vivozon Pharmaceutical082800 · KOSDAQ | ₩3,095 | +5.45% | +6.72% | +11.13% | ₩792M | ₩188B | — |
GC WellBeing234690 · KOSDAQ | ₩10,450 | −7.11% | −6.95% | +12.73% | ₩3.1B | ₩188B | 0.35% |
Boditech Med206640 · KOSDAQ | ₩8,400 | −1.87% | −2.10% | −10.92% | ₩197M | ₩184B | 2.91% |
Chongkundang Holdings001630 · KOSPI | ₩35,600 | +0.56% | +0.14% | −4.43% | ₩100M | ₩178B | 4.29% |
curacle365270 · KOSDAQ | ₩7,950 | −0.87% | −8.30% | −19.21% | ₩122M | ₩176B | 0.50% |
Kangstem Biotech217730 · KOSDAQ | ₩1,872 | −1.42% | +2.07% | −10.86% | ₩598M | ₩176B | 0.10% |
Bioneercorporation064550 · KOSDAQ | ₩6,810 | −2.44% | −6.07% | −19.02% | ₩927M | ₩176B | 0.10% |
Reyon Pharmaceutical102460 · KOSPI | ₩9,370 | +0.11% | −3.80% | −6.02% | ₩121M | ₩174B | 0.61% |
DuChemBio176750 · KOSDAQ | ₩6,090 | −4.84% | −21.11% | −15.88% | ₩1.2B | ₩173B | 0.04% |
DAE HWA Pharm067080 · KOSDAQ | ₩9,170 | −1.93% | −7.65% | −20.67% | ₩239M | ₩171B | 0.08% |
Helixmith084990 · KOSDAQ | ₩3,700 | +2.21% | −5.25% | +15.26% | ₩493M | ₩171B | 0.12% |
Yungjin Pharm003520 · KOSPI | ₩931 | 0.00% | −5.58% | −9.35% | ₩399M | ₩170B | 0.49% |
3billion394800 · KOSDAQ | ₩5,350 | −13.01% | +7.00% | −19.31% | ₩3.4B | ₩170B | 4.02% |
Eone Diagnomics Genome Center245620 · KOSDAQ | ₩741 | 0.00% | 0.00% | 0.00% | ₩0 | ₩167B | — |
JW Lifescience234080 · KOSPI | ₩10,510 | −0.76% | −0.10% | −4.11% | ₩160M | ₩166B | 0.72% |
Samil Pharmaceutical000520 · KOSPI | ₩7,650 | −0.52% | −7.05% | −5.56% | ₩242M | ₩166B | 0.67% |
Kolon Life Science102940 · KOSDAQ | ₩12,410 | −3.27% | −3.80% | −10.40% | ₩784M | ₩162B | 0.50% |
BNC Korea256840 · KOSDAQ | ₩2,350 | −3.29% | −8.20% | −28.35% | ₩1B | ₩161B | — |
Nibec138610 · KOSDAQ | ₩13,620 | −3.95% | −8.34% | −11.15% | ₩550M | ₩155B | 0.84% |
Cellbion308430 · KOSDAQ | ₩11,670 | −8.25% | −1.19% | −22.04% | ₩220M | ₩151B | — |
Kyungdong Pharm011040 · KOSDAQ | ₩4,850 | −1.32% | −1.02% | −3.77% | ₩44M | ₩149B | 0.02% |
Daehan Pharmaceutical023910 · KOSDAQ | ₩24,750 | −1.00% | −2.17% | −5.89% | ₩130M | ₩149B | 1.35% |
Hana Pharm293480 · KOSPI | ₩8,070 | −1.94% | −2.30% | −2.06% | ₩221M | ₩143B | 0.63% |
Aptabio Therapeutics293780 · KOSDAQ | ₩5,090 | −4.14% | −18.43% | −26.23% | ₩358M | ₩143B | 0.05% |
Dongwha Pharm000020 · KOSPI | ₩5,100 | −1.16% | −3.04% | +0.59% | ₩520M | ₩142B | 0.61% |
ISU Abxis086890 · KOSDAQ | ₩3,435 | −1.58% | −3.24% | −10.78% | ₩201M | ₩140B | 0.20% |
Bio Solution086820 · KOSDAQ | ₩5,370 | −1.65% | −6.12% | −18.51% | ₩194M | ₩139B | 0.15% |
Cell Biotech049960 · KOSDAQ | ₩14,800 | 0.00% | −1.27% | −1.27% | ₩71M | ₩139B | 0.00% |
Y-Biologics338840 · KOSDAQ | ₩8,950 | −3.24% | −12.60% | +11.46% | ₩623M | ₩138B | 0.17% |
Ilyang Pharmaceutical007570 · KOSPI | ₩6,960 | +0.72% | −0.57% | −13.11% | ₩96M | ₩133B | 0.43% |
Ensol Biosciences140610 · KONEX | ₩8,840 | −3.70% | +12.90% | −9.61% | ₩16M | ₩127B | — |
Jeil Pharmaceutical271980 · KOSPI | ₩8,600 | −2.60% | −4.02% | −13.48% | ₩66M | ₩126B | 0.70% |
JW Shinyak067290 · KOSDAQ | ₩2,220 | −3.48% | −6.92% | −24.62% | ₩2.6B | ₩124B | — |
Ahn-Gook Pharmaceutical001540 · KOSDAQ | ₩9,450 | −0.42% | +2.16% | −5.12% | ₩526M | ₩123B | — |
Kyongbo Pharmaceutical214390 · KOSPI | ₩5,140 | −0.19% | +0.19% | −3.75% | ₩82M | ₩123B | 0.45% |
Pharmaresearch Bio217950 · KONEX | ₩29,250 | +0.17% | +1.56% | +0.86% | ₩11M | ₩122B | — |
Kanaph Therapeutics0082N0 · KOSDAQ | ₩9,100 | −5.70% | −9.81% | −25.96% | ₩599M | ₩121B | — |
Dongsung Pharmaceutical002210 · KOSPI | ₩1,196 | −2.21% | −7.21% | −4.40% | ₩68M | ₩116B | 0.00% |
Samsung Pharmaceutical001360 · KOSPI | ₩1,203 | −2.20% | −5.35% | −6.74% | ₩320M | ₩113B | 0.27% |
Handok002390 · KOSPI | ₩8,210 | −2.03% | −1.32% | −3.41% | ₩28M | ₩113B | 0.44% |
Kukjeon307750 · KOSDAQ | ₩2,055 | −0.96% | −10.85% | −9.67% | ₩308M | ₩111B | — |
TiumBio321550 · KOSDAQ | ₩3,635 | −2.15% | −10.91% | −18.86% | ₩863M | ₩109B | 0.31% |
MedPacto235980 · KOSDAQ | ₩3,050 | +2.69% | −0.16% | +4.81% | ₩306M | ₩105B | 2.96% |
Celemics331920 · KOSDAQ | ₩9,230 | +0.11% | −4.55% | −13.50% | ₩792M | ₩103B | — |
Optus Pharmaceutical131030 · KOSDAQ | ₩5,810 | −1.36% | −2.19% | −1.53% | ₩86M | ₩103B | — |
Keeps Biopharma256940 · KOSDAQ | ₩5,100 | −3.95% | −7.61% | −15.84% | ₩239M | ₩102B | — |
Sewoonmedical100700 · KOSDAQ | ₩2,275 | −1.30% | 0.00% | −0.87% | ₩162M | ₩100B | 0.68% |
Asta246720 · KOSDAQ | ₩6,070 | 0.00% | 0.00% | 0.00% | ₩0 | ₩99B | — |
Metabiomed059210 · KOSDAQ | ₩3,635 | +0.28% | −1.22% | −0.41% | ₩396M | ₩99B | — |
Genexine095700 · KOSDAQ | ₩2,160 | −0.23% | −11.48% | −19.25% | ₩318M | ₩98B | 0.15% |
DreamCIS223250 · KOSDAQ | ₩3,990 | −0.25% | −4.20% | +16.84% | ₩1.4B | ₩98B | — |
Aribiolab261780 · KOSDAQ | ₩3,350 | +0.15% | −7.84% | −10.79% | ₩661M | ₩97B | — |
ViGenCell308080 · KOSDAQ | ₩4,655 | −4.41% | −6.43% | −15.97% | ₩399M | ₩95B | 0.59% |
DongKoo Bio & Pharma006620 · KOSDAQ | ₩3,250 | +3.83% | −1.52% | −5.93% | ₩226M | ₩93B | — |
HLB bioStep278650 · KOSDAQ | ₩5,290 | +0.76% | −18.99% | +53.78% | ₩9.5B | ₩92B | — |
High Tech Pharm106190 · KOSDAQ | ₩8,650 | −1.70% | −5.15% | −12.54% | ₩84M | ₩92B | — |
Aminologics074430 · KOSDAQ | ₩1,009 | +0.90% | +2.02% | −5.08% | ₩85M | ₩90B | — |
Prestige Biologics334970 · KOSDAQ | ₩1,158 | −2.93% | −8.10% | −16.21% | ₩226M | ₩90B | — |
Sam-A Pharm009300 · KOSDAQ | ₩13,630 | −0.15% | +0.52% | −2.36% | ₩131M | ₩87B | — |
T&R Biofab246710 · KOSDAQ | ₩1,820 | −3.04% | −5.45% | −15.55% | ₩522M | ₩87B | 0.95% |
Vaxcell-Bio Therapeutics323990 · KOSDAQ | ₩3,725 | −1.72% | −8.02% | −12.56% | ₩211M | ₩87B | 0.07% |
Corestemchemon166480 · KOSDAQ | ₩1,636 | −1.45% | −3.20% | −24.95% | ₩91M | ₩86B | 0.02% |
iNtRON Biotechnology048530 · KOSDAQ | ₩2,790 | −2.96% | −8.97% | −1.41% | ₩375M | ₩86B | 1.38% |
Korea Pharma032300 · KOSDAQ | ₩7,770 | −0.38% | −3.24% | +7.02% | ₩135M | ₩85B | — |
Withus Pharmaceutical330350 · KOSDAQ | ₩6,370 | +0.16% | −2.45% | −11.03% | ₩840M | ₩84B | — |
Cellumed049180 · KOSDAQ | ₩1,009 | 0.00% | 0.00% | 0.00% | ₩0 | ₩84B | — |
Enzychem Lifesciences183490 · KOSDAQ | ₩990 | 0.00% | 0.00% | 0.00% | ₩0 | ₩84B | 0.30% |
Choong ANG Vaccine Laboratory072020 · KOSDAQ | ₩8,810 | −0.68% | −1.01% | −3.19% | ₩72M | ₩82B | — |
Bio-Fd&C251120 · KOSDAQ | ₩9,140 | −0.65% | −5.77% | −3.99% | ₩68M | ₩79B | 0.59% |
HLB Genex187420 · KOSDAQ | ₩2,360 | +4.66% | +3.96% | +15.97% | ₩625M | ₩77B | — |
SCL Science246960 · KOSDAQ | ₩2,140 | −3.17% | −6.96% | −23.43% | ₩373M | ₩74B | — |
GC Medical Science142280 · KOSDAQ | ₩3,085 | −2.37% | −11.86% | −1.91% | ₩1.6B | ₩74B | — |
Polaris AI Pharma041910 · KOSDAQ | ₩5,550 | −0.54% | −2.29% | +1.65% | ₩87M | ₩74B | — |
Eye Gene185490 · KOSDAQ | ₩1,705 | −2.57% | −5.44% | −11.34% | ₩69M | ₩74B | 2.40% |
Daehan Nupharm054670 · KOSDAQ | ₩5,100 | −0.20% | −1.73% | −5.73% | ₩190M | ₩73B | — |
Shinil Pharmaceutical012790 · KOSDAQ | ₩6,090 | −2.87% | −0.81% | −0.49% | ₩125M | ₩73B | 0.39% |
Theragen Etex066700 · KOSDAQ | ₩1,980 | +0.25% | −1.74% | −11.80% | ₩60M | ₩73B | 0.40% |
Daebonglsco078140 · KOSDAQ | ₩6,550 | −1.36% | −3.68% | −15.48% | ₩79M | ₩73B | 2.30% |
Choolip & Sciences291650 · KOSDAQ | ₩2,375 | +3.26% | −4.62% | +26.26% | ₩78M | ₩72B | — |
Pharos iBio388870 · KOSDAQ | ₩5,580 | −3.46% | −6.38% | −2.28% | ₩153M | ₩72B | — |
Samik Pharm014950 · KOSDAQ | ₩7,080 | −8.29% | −3.93% | −20.00% | ₩7.3B | ₩71B | — |
Kukje Pharma002720 · KOSPI | ₩3,345 | −1.62% | −5.64% | +3.08% | ₩1.5B | ₩71B | 0.33% |
Sugentech253840 · KOSDAQ | ₩4,060 | −0.61% | −3.10% | −7.62% | ₩179M | ₩68B | — |
Access Bio950130 · KOSDAQ | ₩1,924 | +0.21% | −1.79% | −11.34% | ₩50M | ₩68B | 0.00% |
CKD Bio063160 · KOSPI | ₩12,330 | −0.16% | −1.36% | −4.71% | ₩47M | ₩68B | 0.62% |
DongKook Life Science303810 · KOSDAQ | ₩2,095 | −2.33% | −10.09% | −30.17% | ₩508M | ₩67B | — |
Naturalendo Tech168330 · KOSDAQ | ₩2,090 | +1.21% | +1.21% | −9.91% | ₩6.5M | ₩66B | 0.10% |
Ildong Holdings000230 · KOSPI | ₩5,660 | −1.22% | −3.74% | −4.39% | ₩112M | ₩65B | 0.32% |
CG Invites083790 · KOSDAQ | ₩841 | −4.10% | −3.44% | −15.73% | ₩106M | ₩65B | — |
SunBio067370 · KOSDAQ | ₩5,250 | −5.06% | −5.41% | −2.60% | ₩14M | ₩64B | — |
PharmGen Science004720 · KOSPI | ₩2,765 | +0.55% | −0.36% | −3.15% | ₩57M | ₩63B | 0.08% |
CTC Bio060590 · KOSDAQ | ₩2,585 | −1.90% | −4.44% | −15.52% | ₩61M | ₩63B | — |
Inventera0007J0 · KOSDAQ | ₩7,920 | −5.04% | −9.49% | −41.07% | ₩419M | ₩62B | — |
Optipharm153710 · KOSDAQ | ₩4,245 | −2.30% | −1.28% | −9.49% | ₩34M | ₩62B | 0.44% |
CMG Pharmaceutical058820 · KOSDAQ | ₩4,170 | −4.58% | −25.80% | −24.59% | ₩363M | ₩62B | 0.03% |
Abion203400 · KOSDAQ | ₩3,380 | 0.00% | 0.00% | 0.00% | ₩0 | ₩61B | 0.98% |
Sinsin Pharmaceutical002800 · KOSDAQ | ₩3,975 | −1.49% | −2.57% | −10.17% | ₩161M | ₩60B | — |
Adbiotech179530 · KOSDAQ | ₩1,886 | −2.28% | −8.45% | +2.61% | ₩50M | ₩59B | — |
Pangen Biotech222110 · KOSDAQ | ₩4,285 | −7.05% | −8.93% | −9.31% | ₩92M | ₩58B | — |
Humasis205470 · KOSDAQ | ₩2,330 | −2.31% | −6.05% | −8.98% | ₩219M | ₩57B | 0.00% |
Yuyu Pharma000220 · KOSPI | ₩3,650 | 0.00% | 0.00% | −1.35% | ₩219M | ₩57B | 0.12% |
Imgt456570 · KONEX | ₩10,900 | +2.16% | +8.67% | −17.30% | ₩610,370 | ₩57B | — |
HLB Panagene046210 · KOSDAQ | ₩1,259 | −0.47% | −9.62% | −2.02% | ₩291M | ₩57B | — |
Tego Science191420 · KOSDAQ | ₩7,040 | −3.03% | +1.73% | −2.49% | ₩8.1M | ₩57B | — |
Cellid299660 · KOSDAQ | ₩1,882 | +1.13% | −11.23% | −21.42% | ₩313M | ₩56B | 0.02% |
HL Genomics0156T0 · KOSDAQ | ₩7,000 | −1.69% | −2.78% | −14.11% | ₩229M | ₩54B | — |
NeoImmuneTech950220 · KOSDAQ | ₩1,576 | −3.43% | −1.50% | −16.83% | ₩199M | ₩54B | — |
Cytogen217330 · KOSDAQ | ₩2,315 | −1.28% | −7.58% | −23.60% | ₩125M | ₩54B | — |
KoBioLabs348150 · KOSDAQ | ₩2,670 | −1.84% | +1.52% | −1.66% | ₩27M | ₩52B | — |
ENCell456070 · KOSDAQ | ₩4,675 | −3.81% | −3.11% | −19.54% | ₩198M | ₩52B | — |
NovMetaPharma229500 · KONEX | ₩3,880 | +14.96% | +5.43% | −29.71% | ₩83M | ₩50B | — |
GeneOne Life Science011000 · KOSPI | ₩2,670 | 0.00% | 0.00% | 0.00% | ₩0 | ₩49B | 0.19% |
Epi Biotech446440 · KONEX | ₩21,000 | −2.33% | +5.00% | +31.58% | ₩313,900 | ₩48B | — |
CJ Bioscience311690 · KOSDAQ | ₩3,695 | +0.14% | +2.50% | −0.94% | ₩11M | ₩48B | — |
JIN Yang Pharmaceutical007370 · KOSDAQ | ₩3,405 | −1.45% | −6.20% | −14.77% | ₩99M | ₩48B | — |
Aprogen007460 · KOSPI | ₩1,870 | −1.42% | −1.58% | −4.40% | ₩249M | ₩48B | 0.76% |
QuadMedicine464490 · KOSDAQ | ₩4,150 | +0.61% | +0.48% | −7.68% | ₩142M | ₩48B | — |
Hwail Pharm061250 · KOSDAQ | ₩5,600 | −2.61% | −5.41% | −12.09% | ₩15M | ₩47B | — |
Geninus389030 · KOSDAQ | ₩1,183 | −5.36% | −16.45% | −46.95% | ₩625M | ₩47B | — |
Gencurix229000 · KOSDAQ | ₩1,957 | 0.00% | 0.00% | 0.00% | ₩0 | ₩46B | 0.81% |
Quratis348080 · KOSDAQ | ₩3,515 | 0.00% | +5.56% | −8.82% | ₩49M | ₩45B | — |
RPbio314140 · KOSDAQ | ₩5,080 | −3.24% | −6.45% | −14.62% | ₩20M | ₩44B | — |
Aprogen Biologics003060 · KOSPI | ₩1,335 | −3.26% | −3.75% | −11.41% | ₩125M | ₩40B | 0.08% |
Green Lifescience114450 · KOSDAQ | ₩1,990 | −1.97% | −8.72% | −10.36% | ₩209M | ₩40B | — |
Wonbiogen307280 · KOSDAQ | ₩5,500 | −2.14% | −3.00% | −6.78% | ₩103M | ₩39B | — |
Myungmoon Pharm017180 · KOSPI | ₩1,136 | −1.22% | −5.18% | −8.68% | ₩28M | ₩39B | 0.30% |
Oncocross382150 · KOSDAQ | ₩2,875 | −5.12% | −6.20% | −23.54% | ₩135M | ₩38B | — |
HLB Pep196300 · KOSDAQ | ₩3,810 | −6.27% | −8.30% | −16.26% | ₩65M | ₩36B | — |
Kainos Medicine284620 · KOSDAQ | ₩1,087 | 0.00% | 0.00% | 0.00% | ₩0 | ₩36B | — |
Organoidsciences476040 · KOSDAQ | ₩5,460 | −3.87% | −10.49% | −18.99% | ₩89M | ₩36B | 1.38% |
Eutilex263050 · KOSDAQ | ₩959 | 0.00% | 0.00% | 0.00% | ₩0 | ₩35B | 0.74% |
Orientbio002630 · KOSPI | ₩1,190 | −3.17% | −12.50% | −30.04% | ₩38M | ₩35B | 0.06% |
Kolmar BioTech215380 · KOSDAQ | ₩2,045 | −3.76% | −1.21% | −7.88% | ₩48M | ₩34B | — |
IMBdx461030 · KOSDAQ | ₩2,395 | 0.00% | −4.01% | −11.62% | ₩21M | ₩34B | 0.31% |
Genolution225220 · KOSDAQ | ₩1,724 | +0.23% | +6.42% | +18.73% | ₩105M | ₩33B | — |
Kyung NAM Pharm053950 · KOSDAQ | ₩1,675 | −2.05% | −5.15% | −16.12% | ₩91M | ₩33B | — |
Hass450330 · KOSDAQ | ₩3,975 | −2.69% | −10.47% | −14.15% | ₩11M | ₩33B | — |
Biotoxtech086040 · KOSDAQ | ₩1,999 | −1.53% | −2.49% | −10.76% | ₩28M | ₩32B | — |
LabGenomics084650 · KOSDAQ | ₩2,095 | +4.23% | +23.24% | −17.03% | ₩94M | ₩31B | 0.58% |
ProGen296160 · KONEX | ₩2,020 | −0.98% | −1.22% | −17.04% | ₩4.9M | ₩31B | — |
Korean Drug014570 · KOSDAQ | ₩2,810 | −1.06% | −4.75% | −13.54% | ₩34M | ₩31B | — |
Bcworldpharm200780 · KOSDAQ | ₩2,790 | −1.06% | −2.11% | −7.00% | ₩11M | ₩30B | 0.20% |
Genematrix109820 · KOSDAQ | ₩1,403 | −1.13% | −5.90% | −8.54% | ₩63M | ₩29B | — |
Korea Arlico Pharm260660 · KOSDAQ | ₩1,864 | −0.85% | −7.26% | −18.60% | ₩21M | ₩29B | — |
Tdspharm464280 · KOSDAQ | ₩4,500 | −3.43% | −8.26% | −16.97% | ₩22M | ₩25B | — |
Dt&Cro383930 · KOSDAQ | ₩1,836 | −2.91% | −14.41% | −2.81% | ₩34M | ₩23B | — |
Poongjeon Pharmacy298060 · KOSDAQ | ₩2,350 | −1.05% | +3.30% | −0.63% | ₩35M | ₩23B | — |
BASKHANBIOPharma354390 · KONEX | ₩3,215 | −8.01% | −9.56% | −8.14% | ₩3,215 | ₩23B | — |
Daesung Microbiological Labs036480 · KOSDAQ | ₩5,490 | −0.54% | −2.66% | −8.04% | ₩7.4M | ₩21B | — |
Shaperon378800 · KOSDAQ | ₩2,220 | −4.93% | −4.93% | −12.25% | ₩80M | ₩21B | — |
Seoul Pharma018680 · KOSDAQ | ₩1,691 | −5.11% | −9.57% | −13.59% | ₩37M | ₩20B | — |
MFC432980 · KOSDAQ | ₩2,245 | −1.97% | −3.44% | −9.11% | ₩6.4M | ₩19B | — |
WooGene B&Gco018620 · KOSDAQ | ₩2,760 | −4.33% | −3.83% | +2.22% | ₩48M | ₩19B | — |
Telcon RF Pharmaceutical200230 · KOSDAQ | ₩1,992 | −1.63% | −4.69% | −7.78% | ₩14M | ₩19B | 0.20% |
Plumbline Life Sciences222670 · KONEX | ₩4,635 | 0.00% | 0.00% | 0.00% | ₩0 | ₩19B | — |
Moogene Medi322970 · KONEX | ₩1,796 | −2.66% | −4.21% | −3.91% | ₩3M | ₩18B | — |
Xcell Therapeutics373110 · KOSDAQ | ₩973 | −2.51% | −5.35% | −2.60% | ₩24M | ₩17B | — |
PCL241820 · KOSDAQ | ₩6,040 | 0.00% | 0.00% | 0.00% | ₩0 | ₩17B | — |
PeopleBio304840 · KOSDAQ | ₩561 | 0.00% | 0.00% | 0.00% | ₩0 | ₩14B | — |
Celestra352770 · KOSDAQ | ₩5,250 | 0.00% | 0.00% | 0.00% | ₩0 | ₩14B | — |
Olipass244460 · KOSDAQ | ₩1,651 | 0.00% | 0.00% | 0.00% | ₩0 | ₩13B | — |
Curachem456190 · KONEX | ₩7,210 | 0.00% | 0.00% | 0.00% | ₩0 | ₩13B | — |
Invites Biocore216400 · KONEX | ₩1,389 | −0.79% | +1.46% | +1.39% | ₩204,026 | ₩11B | — |
ChoA Pharmaceutical034940 · KOSDAQ | ₩1,704 | −0.23% | −7.69% | −34.96% | ₩54M | ₩11B | — |
Median Diagnostics233250 · KONEX | ₩4,800 | 0.00% | −2.04% | 0.00% | ₩0 | ₩8.4B | — |
AngioLab251280 · KONEX | ₩2,185 | −6.82% | −12.25% | −19.07% | ₩5.7M | ₩8B | — |
BioInfra199730 · KOSDAQ | ₩1,350 | −0.88% | −22.90% | +93.69% | ₩298M | ₩6.6B | — |
MOA Life Plus142760 · KOSDAQ | ₩220 | −6.78% | −56.00% | −55.10% | ₩202M | ₩4.6B | — |
Cronex215570 · KONEX | ₩600 | +0.33% | 0.00% | 0.00% | ₩121,210 | ₩4B | — |
Medizen Humancare236340 · KONEX | ₩1,300 | +4.84% | 0.00% | −37.95% | ₩5,300 | ₩4B | — |
BioInfra Life Science266470 · KONEX | ₩104 | +5.05% | +9.47% | +8.33% | ₩28,043 | ₩2.9B | — |
Source: KRX statistical information